20250114 bayer handout jpm 2025

Slide schematic 7/7

list 3/3 other 3/3 title 1/1

Components 7

bullet bullet bullet unclassified unclassified unclassified headline

Tools 1

list/bullet: Managing through increasing Xarelto LoE pressures; Base business remains resilient; Launch of Eylea 8mg including Pre-filled Syringe underway; Continued strong uptake of launch brands Nubeqa and Kerendia; La

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide uses a three-column layout to categorize strategic progress.